Literature DB >> 5116171

Treatment of mucocutaneous (American) leishmaniasis with amphotericin B: report of 70 cases.

S A Sampaio, R M Castro, N L Dillon, J E Martins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5116171     DOI： 10.1111/j.1365-4362.1971.tb01694.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  10 in total

Review 1.  Leishmaniasis.

Authors:  T V Piscopo; A C Mallia
Journal:  Postgrad Med J       Date:  2006-10       Impact factor: 2.401

Review 2.  Therapy and prophylaxis of systemic protozoan infections.

Authors:  W C Van Voorhis
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

3.  A species-specific approach to the use of non-antimony treatments for cutaneous leishmaniasis.

Authors:  Roshan Ramanathan; Kawsar R Talaat; Daniel P Fedorko; Siddhartha Mahanty; Theodore E Nash
Journal:  Am J Trop Med Hyg       Date:  2011-01       Impact factor: 2.345

4.  Potent plasmodicidal activity of a heat-induced reformulation of deoxycholate-amphotericin B (Fungizone) against Plasmodium falciparum.

Authors:  Toshimitsu Hatabu; Tsuyoshi Takada; Nao Taguchi; Mamoru Suzuki; Kumiko Sato; Shigeyuki Kano
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

Review 5.  Leishmaniasis.

Authors:  Tonio V Piscopo; Charles Mallia Azzopardi
Journal:  Postgrad Med J       Date:  2007-02       Impact factor: 2.401

6.  Case Report: Mucosal Leishmaniasis Presenting with Nasal Septum Perforation after Almost Thirty Years.

Authors:  Jesùs Rojas-Jaimes; Helena L Frischtak; Jose Arenas; Andres G Lescano
Journal:  Am J Trop Med Hyg       Date:  2018-05-31       Impact factor: 2.345

7.  Efficacy of amphotericin B in multi-drug resistant kala-azar in children in first decade of life.

Authors:  C P Thakur; G P Sinha; V Sharma; A K Pandey; P K Sinha; D Barat
Journal:  Indian J Pediatr       Date:  1993 Jan-Feb       Impact factor: 1.967

8.  Severe mucosal leishmaniasis with torpid and fatal evolution.

Authors:  Jesús Rojas Jaimes
Journal:  Clin Case Rep       Date:  2022-08-14

9.  Meglumine antimoniate was associated with a higher cure rate than liposomal amphotericin B in the treatment of American tegumentary leishmaniasis: A retrospective cohort study from a Leishmania braziliensis-endemic area.

Authors:  Daniel Holanda Barroso; Renata Trindade Gonçalves; Joadyson Silva Barbosa; Jorgeth de Oliveira Carneiro da Motta; Gustavo Subtil Magalhães Freire; Ciro Martins Gomes; Raimunda Nonata Ribeiro Sampaio
Journal:  Front Cell Infect Microbiol       Date:  2022-09-23       Impact factor: 6.073

10.  Intraspecies differences in natural susceptibility to amphotericine B of clinical isolates of Leishmania subgenus Viannia.

Authors:  Carlos Franco-Muñoz; Merab Manjarrés-Estremor; Clemencia Ovalle-Bracho
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.